These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

580 related items for PubMed ID: 17599769

  • 21. Overexpression of collagen XVIII is associated with poor outcome and elevated levels of circulating serum endostatin in non-small cell lung cancer.
    Iizasa T, Chang H, Suzuki M, Otsuji M, Yokoi S, Chiyo M, Motohashi S, Yasufuku K, Sekine Y, Iyoda A, Shibuya K, Hiroshima K, Fujisawa T.
    Clin Cancer Res; 2004 Aug 15; 10(16):5361-6. PubMed ID: 15328173
    [Abstract] [Full Text] [Related]

  • 22. Postoperative serum carcinoembryonic antigen levels in patients with pathologic stage IA nonsmall cell lung carcinoma: subnormal levels as an indicator of favorable prognosis.
    Sawabata N, Maeda H, Yokota S, Takeda S, Koma M, Tokunaga T, Ito M.
    Cancer; 2004 Aug 15; 101(4):803-9. PubMed ID: 15305413
    [Abstract] [Full Text] [Related]

  • 23. A prognostic model for advanced stage nonsmall cell lung cancer. Pooled analysis of North Central Cancer Treatment Group trials.
    Mandrekar SJ, Schild SE, Hillman SL, Allen KL, Marks RS, Mailliard JA, Krook JE, Maksymiuk AW, Chansky K, Kelly K, Adjei AA, Jett JR.
    Cancer; 2006 Aug 15; 107(4):781-92. PubMed ID: 16847887
    [Abstract] [Full Text] [Related]

  • 24. Centromere protein H is a novel prognostic marker for human nonsmall cell lung cancer progression and overall patient survival.
    Liao WT, Wang X, Xu LH, Kong QL, Yu CP, Li MZ, Shi L, Zeng MS, Song LB.
    Cancer; 2009 Apr 01; 115(7):1507-17. PubMed ID: 19170237
    [Abstract] [Full Text] [Related]

  • 25. Soluble TNF and IL-2 receptors in patients with breast cancer.
    Tesarová P, Kvasnicka J, Umlaufová A, Homolková H, Jirsa M, Tesar V.
    Med Sci Monit; 2000 Apr 01; 6(4):661-7. PubMed ID: 11208388
    [Abstract] [Full Text] [Related]

  • 26. Chromogranin A in heart failure; a novel neurohumoral factor and a predictor for mortality.
    Ceconi C, Ferrari R, Bachetti T, Opasich C, Volterrani M, Colombo B, Parrinello G, Corti A.
    Eur Heart J; 2002 Jun 01; 23(12):967-74. PubMed ID: 12069452
    [Abstract] [Full Text] [Related]

  • 27. [Influence of overexpressed coagulant and fibrolytic components in tumor tissues on the prognosis of non-small cell lung cancer].
    Chen WH, Wang C, Zhang YH, Yang YH, Zhan HY, Zhang LM.
    Zhonghua Yi Xue Za Zhi; 2007 Dec 04; 87(45):3228-32. PubMed ID: 18399120
    [Abstract] [Full Text] [Related]

  • 28. Soluble syndecan-1 and serum basic fibroblast growth factor are new prognostic factors in lung cancer.
    Joensuu H, Anttonen A, Eriksson M, Mäkitaro R, Alfthan H, Kinnula V, Leppä S.
    Cancer Res; 2002 Sep 15; 62(18):5210-7. PubMed ID: 12234986
    [Abstract] [Full Text] [Related]

  • 29. Expression of class III {beta}-tubulin is predictive of patient outcome in patients with non-small cell lung cancer receiving vinorelbine-based chemotherapy.
    Sève P, Isaac S, Trédan O, Souquet PJ, Pachéco Y, Pérol M, Lafanéchère L, Penet A, Peiller EL, Dumontet C.
    Clin Cancer Res; 2005 Aug 01; 11(15):5481-6. PubMed ID: 16061864
    [Abstract] [Full Text] [Related]

  • 30. Chromogranin-A and N-terminal pro-brain natriuretic peptide: an excellent pair of biomarkers for diagnostics in patients with neuroendocrine tumor.
    Korse CM, Taal BG, de Groot CA, Bakker RH, Bonfrer JM.
    J Clin Oncol; 2009 Sep 10; 27(26):4293-9. PubMed ID: 19667278
    [Abstract] [Full Text] [Related]

  • 31. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.
    De Petris L, Orre LM, Kanter L, Pernemalm M, Koyi H, Lewensohn R, Lehtiö J.
    Lung Cancer; 2009 Mar 10; 63(3):410-7. PubMed ID: 18620780
    [Abstract] [Full Text] [Related]

  • 32. Preoperative CYFRA 21-1 levels as a prognostic factor in c-stage I non-small cell lung cancer.
    Suzuki H, Ishikawa S, Satoh H, Ishikawa H, Sakai M, Yamamoto T, Onizuka M, Sakakibara Y.
    Eur J Cardiothorac Surg; 2007 Oct 10; 32(4):648-52. PubMed ID: 17707649
    [Abstract] [Full Text] [Related]

  • 33. Prognostic significance of proliferation activity and neuroendocrine differentiation to predict treatment failure after radical prostatectomy.
    May M, Siegsmund M, Hammermann F, Loy V, Gunia S.
    Scand J Urol Nephrol; 2007 Oct 10; 41(5):375-81. PubMed ID: 17853019
    [Abstract] [Full Text] [Related]

  • 34. Combined analysis of cyclooxygenase-2 expression with p53 and Ki-67 in nonsmall cell lung cancer.
    Tsubochi H, Sato N, Hiyama M, Kaimori M, Endo S, Sohara Y, Imai T.
    Ann Thorac Surg; 2006 Oct 10; 82(4):1198-204. PubMed ID: 16996907
    [Abstract] [Full Text] [Related]

  • 35. Circulating aminopeptidase N/CD13 is an independent prognostic factor in patients with non-small cell lung cancer.
    Murakami H, Yokoyama A, Kondo K, Nakanishi S, Kohno N, Miyake M.
    Clin Cancer Res; 2005 Dec 15; 11(24 Pt 1):8674-9. PubMed ID: 16361553
    [Abstract] [Full Text] [Related]

  • 36. The favorable prognostic significance of atelectasis in patients with advanced non-small cell lung cancer: results of a prospective observational study.
    Dediu M, Crisan E, Radut M, Tarlea A, Median D, Alexandru A, Vremes G, Gal C.
    Lung Cancer; 2009 Feb 15; 63(2):271-6. PubMed ID: 18565617
    [Abstract] [Full Text] [Related]

  • 37. Chromogranin A gene expression in non-small cell lung carcinomas.
    Abbona G, Papotti M, Viberti L, Macrĭ L, Stella A, Bussolati G.
    J Pathol; 1998 Oct 15; 186(2):151-6. PubMed ID: 9924430
    [Abstract] [Full Text] [Related]

  • 38. The prognostic value of serum epidermal growth factor receptor level in patients with non-small cell lung cancer.
    Ciledağ A, Kaya A, Yetkin O, Poyraz B, Savaş I, Numanoğlu N, Savaş H.
    Tuberk Toraks; 2008 Oct 15; 56(4):390-5. PubMed ID: 19123074
    [Abstract] [Full Text] [Related]

  • 39. The significance of serum levels of soluble 60kDa receptors for tumor necrosis factor in patients with Hodgkin's disease.
    Gruss HJ, Dölken G, Brach MA, Mertelsmann R, Herrmann F.
    Leukemia; 1993 Sep 15; 7(9):1339-43. PubMed ID: 8396696
    [Abstract] [Full Text] [Related]

  • 40. Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer.
    Matsuoka K, Sumitomo S, Nakashima N, Nakajima D, Misaki N.
    Eur J Cardiothorac Surg; 2007 Sep 15; 32(3):435-9. PubMed ID: 17611117
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.